Cannabis plant extracts could potentially form the basic ingredients for a market-leading diabetes drug, the scientist who developed a former world-beating treatment for the condition believes.
Cawthorne said that the cannabinoid CBD, used along with THC in GW Pharma's Sativex drug, has been seen to raise levels of "good" cholesterol in animals. While "bad" cholesterol can build up in the blood vessels and cause strokes or heart attacks, "good" cholesterol is thought to protect against heart attacks.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||RESEARCH & TECHNOLOGY; GlaxoSmithKline PLC; GW Pharmaceuticals|
|Article Type:||Brief article|
|Date:||Jun 22, 2009|
|Previous Article:||Weekly key rates.|
|Next Article:||A cream used to treat the early signs of skin cancer may erase wrinkles and leave behind younger-looking skin, US researchers said.|